Spirulina and Ménière’s disease.

Ménière’s pathophysiology

The inner ear endolymph is a unique fluid with high potassium concentration maintained by active ion transport in the stria vascularis. Disruption of this system — resulting in excess endolymph (hydrops) — is the central feature of Ménière’s disease, though the precise trigger remains incompletely understood.

• Microvascular oxidative stress:The stria vascularis and spiral ligament receive their oxygen supply from the cochlear lateral wall microcirculation. NOX2-derived superoxide in cochlear endothelial cells consumes nitric oxide (NO) — reducing vasodilatory capacity, increasing vascular resistance, and impairing the oxygen delivery that ionic transport in the stria vascularis requires.
• Immune activation:Evidence for autoimmune involvement in a subset of Ménière’s cases — elevated systemic inflammatory markers during active phases, with some patients responding to immunosuppression.
• Virus reactivation:HSV-1 and VZV reactivation in the cochlear ganglion is proposed as a trigger in some patients — calcium spirulan has shown inhibitory activity against enveloped virus entry in vitro.
• Endolymphatic sac dysfunction:The endolymphatic sac regulates fluid volume; impaired resorption is the proximate cause of hydrops. Sodium and fluid restriction reduce endolymph production by reducing osmotic drive.

Sodium in spirulina: the management question

The primary lifestyle recommendation for Ménière’s is dietary sodium restriction (typically <1,500–2,000 mg/day) to reduce endolymph production. Spirulina’s sodium content is approximately 150–300 mg per 10 g depending on source and processing (some commercial spirulina is processed with sodium bicarbonate medium that increases residual sodium).

• At 5 g/day: approximately 75–150 mg sodium — a modest contribution relative to dietary total. Compatible with sodium restriction if other dietary sodium is controlled.
• At 10 g/day: 150–300 mg sodium. At the upper end, this is approximately 10–15% of the daily sodium allowance for strict Ménière’s management. Check the specific product’s Nutrition Facts panel for sodium content — this varies significantly between brands.
• Prefer spirulina grown in low-sodium medium — some home-grown and small-batch commercial products have lower sodium than mass-market tablets.

Phycocyanobilin and cochlear microcirculation

The mechanistic case for phycocyanobilin in Ménière’s is:

• NOX2 inhibition in cochlear endothelial cells reduces superoxide generation, protecting NO bioavailability — improving vasodilatory capacity in the stria vascularis microcirculation
• Reduced endothelial oxidative stress may support the ion transport capacity of the stria vascularis, which depends on adequate oxygen and ATP supply
• Anti-inflammatory reduction of NF-κB in cochlear tissue may reduce the inflammatory component of immune-mediated Ménière’s

No clinical trial exists in Ménière’s disease. The mechanism is plausible but entirely extrapolated from vascular oxidative stress models in other tissues.

Iron and inner ear health

Iron deficiency is associated with both tinnitus and sensorineural hearing loss through separate mechanisms:

• Iron is required for myelin synthesis in auditory nerve fibres — deficiency impairs neural conduction velocity and signal fidelity
• Anaemia reduces oxygen delivery to the cochlea — the organ of Corti is extremely metabolically active and sensitive to hypoxia
• Spirulina’s iron provision is relevant if ferritin is low (<50 µg/L) — test before starting; iron deficiency correction may independently benefit hearing symptoms

Practical guidance

• Discuss spirulina with ENT specialist or audiologist managing your Ménière’s — particularly regarding sodium content relative to your prescribed dietary limit
• Choose a spirulina product with transparent sodium labelling; aim for <200 mg per 10 g if on strict sodium restriction
• Test serum ferritin — if below 50 µg/L, iron correction is a priority intervention that may independently support hearing function
• Start at 3–5 g/day and monitor symptom response over 4–6 weeks — Ménière’s is episodic and highly variable; attributing improvement or worsening to any single intervention requires careful symptom journalling
• Standard Ménière’s management (betahistine, sodium restriction, diuretics, intratympanic injections) is primary — spirulina is a supportive adjunct if sodium is manageable